use in Biological Technology

FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics' Focus Diagnostics Business

MADISON, N.J., July 24 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization to the...

American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification

BETHESDA, Md., July 15 /PRNewswire/ -- The American Medical Informatics Association (AMIA) announced today that it had submitted additional written comments to the Office of the National Coordinator (ONC) and the HIT Policy Committee about meaningful use and electronic health record...

Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax

ROCKVILLE, Md., July 9 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) today announced publication by The New England Journal of Medicine of the results of two pivotal animal efficacy studies, which showed the life-saving potential of the Company's human monoclonal an...

AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction

Data published in July 7, 2009 Issue of Proceedings of the National Academy of Sciences QUEBEC CITY, July 7 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced publi...

EFSA Issues Positive Safety Statement for the Use of Chromium Picolinate in EU Food Supplements

The European Food Safety Authority (EFSA) concludes no safety concerns for the use of chromium picolinate in food supplements, in response to Nutrition 21's Application to market Chromax(R) chromium picolinate in Europe . PURCHASE, N.Y., June 30 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. ...

First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes

PHILADELPHIA, June 3 /PRNewswire-FirstCall/ -- Waters Corporation (NYSE: WAT ) announced today that the American Society for Mass Spectrometry (ASMS) presented Prof. Alison Ashcroft of the University of Leeds with the first Ron Hites Award for Outstanding Research Publication in the Journal of t...

Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients

DEERFIELD, Ill., May 28 /PRNewswire/ -- The Food and Drug Administration (FDA) has granted Astellas Pharma US, Inc. approval for the use of Prograf(R) (tacrolimus) in conjunction with mycophenolate mofetil (MMF) for the prevention of organ rejection in kidney transplant recipients. Prograf is a c...

FDA Clears Boston Scientific's SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System

SpyGlass(R) Direct Visualization System can now be used for diagnostic and therapeutic procedures for pancreatic disease NATICK, Mass., May 28 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that it has received 510(k) clearance from the U.S. Food and D...

First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter

BURLINGTON, Mass. and ROTTERDAM, Netherlands, May 19 /PRNewswire/ -- InfraReDx, Inc. announced today the first use in patients of a novel coronary catheter that uses both light and sound to image coronary plaques. Working on a team led by Dr. Patrick Serruys, Dr. Martin van der Ent performed the p...

City of Baltimore to Evaluate New Generation Biofuels for Use in Boiler Applications

LAKE MARY, Fla., May 7 /PRNewswire-FirstCall/ -- Renewable fuels provider New Generation Biofuels Holdings, Inc. (Nasdaq: NGBF ) today announced that it has signed a contract with the City of Baltimore, Maryland,("the City") to provide its renewable biofuel in an evaluation program for boile...

Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species

RICHMOND, Calif., April 29 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today continued success of its zinc finger DNA-binding protein (ZFP) technology. New research published in the scientific journal Nature by licensing partner Dow AgroSciences and Sangamo de...

FDA has Granted HUD (Humanitarian Use Device) Designation to ITGI's Pericardium Covered Stents, Over and Under(R) and Aneugraft(R), for Treatment of Perforations and Dissections of Native Coronary Arteries and Saphenous Vein Grafts

OR AKIVA, Israel, April 28 /PRNewswire-FirstCall/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged in research, development, manufacturing and marketing of heterologous tissue covered stents, announced that the US Food and Drug Administration (FDA) has granted HUD (Humanitarian Use Device)...

deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes

REYKJAVIK, Iceland, and ALAMEDA, California, April 23 /PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ: DCGN ) and Celera Corporation (NASDAQ: CRA ) today announced the signing of agreements under which deCODE has granted Celera non-exclusive worldwide licenses to deCODE's genetic markers f...

Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males

Feedback Can Influence New Product Development and Innovation MOUNTAIN VIEW, Calif., April 22 /PRNewswire/ -- The latest end-user study from Frost & Sullivan's Pharmaceuticals & Biotechnology group assesses a variety of critical dynamics of drug delivery approaches and technologies in...

UH initiative will use 'Harry Potter' to conjure love for science in Houston-area schools

Hoping that science will cast a spell on local middle and high school students, a University of Houston team is starting a program that will harness the magical draw of the Harry Potter series to make technical subjects resonate in local classrooms. Funded by a nearly $3 million grant from the ...

Nearly 70 Percent of Health Professionals Support Biotechnology's Use in Food Products

Biotechnology Recognized as a Tool to Make Soyfoods Even Healthier ST. LOUIS, March 31 /PRNewswire/ -- Recent research reveals that 82 percent of healthcare professionals believe soy to be beneficial to the diet. And, the majority recognizes agricultural biotechnology as a method to make food...

MIT: 'Alarming' use of energy in modern manufacturing methods

CAMBRIDGE, Mass.--Modern manufacturing methods are spectacularly inefficient in their use of energy and materials, according to a detailed MIT analysis of the energy use of 20 major manufacturing processes. Overall, new manufacturing systems are anywhere from 1,000 to one million times bigger c...

Researchers create catalysts for use in hydrogen storage materials

RICHMOND, Va. (March 24, 2009) A team of scientists from Virginia Commonwealth University, the University of Uppsala in Sweden, and the Savannah River National Laboratory have identified that carbon nanostructures can be used as catalysts to store and release hydrogen, a finding that may point re...

GYNECARE PROLIFT+M(TM) Pelvic Floor Repair System Launched in US for Use in Pelvic Organ Prolapse Surgery

First surgical mesh in US to incorporate partially absorbable mesh for use in the treatment of pelvic floor disorders; material designed to improve healing and patient comfort SOMERVILLE, N.J., March 12 /PRNewswire/ -- Ethicon Women's Health & Urology, a division of Ethicon, Inc., a...

AV-1011 Bird Repellent to Protect Rice Seed Approved for Use in Louisiana and Missouri

NEW CASTLE, Del., March 12 /PRNewswire/ ---- Arkion(R) Life Sciences has received their first ever Section 18 approvals to market AV-1011 Liquid Rice Seed Treatment in Louisiana and Missouri effective March 6, 2009, through March 6, 2010. The EPA approval means that rice growers in t...

Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe

However, Off-Label Use of Avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a New Report from Decision Resources WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...

FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery

ISELIN, N.J., March 9 /PRNewswire-FirstCall/ -- SyntheMed, Inc. (OTC Bulletin Board: SYMD), a biomaterials company engaged in the development and commercialization of anti-adhesion products, today announced that the U.S. Food and Drug Administration (FDA) has approved the Pre-market Approval (PMA)...

Frost & Sullivan's Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells

MOUNTAIN VIEW, Calif., March 4 /PRNewswire/ -- The Healthcare practice at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the North American biopharmaceuticals market to be held on Thursday, March 5, 2009 at 10:00 a.m. PST. (Logo: http://www...

Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures

FREMONT, Calif., Feb. 26 /PRNewswire/ -- Biomerix Corporation announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market REVIVE(TM). Constructed using the Biomerix Biomaterial(TM), REVIVE acts as a tissue scaffold facilitating rapid tissue ingrowth and ...

Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss

NEW YORK, Feb. 24 /PRNewswire/ -- Mindset BioPharmaceuticals (USA) Inc ("MINDSET") a company privately held by MPM Capital and other shareholders announced today that it has received a Notice of Allowance in Europe related to patent applications describing the use of insulin sensitizer drugs for t...

10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service

SUNNYVALE, Calif., Feb. 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that 10 percent of its U.S. installed base has signed on to utilize the company's treatment planning service. Treatment planning by medical...

Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines

ROCKVILLE, Md. and NANTES, France, Feb. 4 /PRNewswire-FirstCall/ -- NOVAVAX (Nasdaq: NVAX ) and Vivalis (NYSE Euronext: VLS) announced today the completion of a research license to use the Vivalis proprietary EB66(R) cell line, for the production of Novavax VLP based vaccines. Through this colla...

International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"

BIRMINGHAM, England, January 28 /PRNewswire/ -- The Binding Site Limited ("The Binding Site" or the "Company"), a privately-owned specialist U.K. diagnostics company, today announces the publication of the first international guidelines recommending first-line use of Freelite(TM) in the diagno...

Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease

LAFAYETTE, La., Jan. 14 /PRNewswire/ -- Lafayette General Medical Center (LGMC) announced today it is the first hospital in Louisiana to use a proprietary molecular genetic technology, which includes specific tests that more accurately diagnose respiratory infectious diseases. This technology,...

Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery

SEATTLE, Dec. 9 /PRNewswire/ -- Omeros Corporation today announced favorable results from a Phase 1 vehicle-controlled study of OMS201, another of Omeros' PharmacoSurgery(TM) product candidates, for use during urological surgery. The Phase 1 study of OMS201 enrolled patients undergoing e...

BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization

PRINCETON, N.J., Dec. 8 /PRNewswire/ -- BioWa, Inc., announced today that it licensed to GlaxoSmithKline (NYSE: GSK ) its POTELLIGENT(R) Technology for use in developing and commercializing select GSK antibodies with enhancement of antibody-dependent cellular cytotoxicity (ADCC). "GSK is...

ConjuChem and Novozymes Enter Long-Term Supply Agreement for Recombumin(R) use in PC-DAC(TM):Exendin-4

- Additional Pipeline Product Agreement Executed to Support ConjuChem's R&D Efforts - MONTREAL and BAGSVAERD, Denmark, Dec. 3 /PRNewswire-FirstCall/ - ConjuChem Biotechnologies Inc. (TSX:CJB) and Novozymes Biopharma UK Ltd., a subsidiary of Novozymes A/S (LSE:NVZ) announce...

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies

PARIS, November 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients acceler...

Singapore Medicine - Singapore Doctors Use Hi-Tech Implant to Add Space to Narrowed Spinal Canals

Singapore's ParkwayHealth is the first healthcare group in Southeast Asia to offer the In-Space percutaneous interspinous distraction device, a revolutionary spinal procedure. Singapore (PRWEB) November 18, 2008 -- Singapore's ParkwayHealth is the first healthcare group...

Is Your Decaf Really Decaf? Use New "D+CAF (tm) Caffeine Test Strips" to Know for Sure

Studies show that up to 30% of coffees ordered as "decaf" contain high levels of caffeine. Now you can know for sure with D+CAF, the first do-it-yourself caffeine test strip from Silver Lake Research, the leader in at-home water quality testing ( www.caffeinetest.com ). ...

Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries

New Data Suggest Potential Benefits of Targeted Tissue Cooling During Prostate Surgery SAN DIEGO, Nov. 11 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM ) and its operating unit InnerCool Therapies, Inc., today announced that it has developed a pelvic co...

FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c

- New labeling reinforces strong safety profile of Ranexa - - Conference call scheduled for 8:00 a.m. ET/5:00 a.m. PT - PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX ) announced today that the U.S. Food and Drug Administration (FDA) has approved a ...

PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery

- PlasmaBlade Needle and PlasmaBlade EXT Extend PlasmaBlade Family of Tissue Dissection Tools, Which Have Been Used in More Than 150 Surgical Procedures Since FDA Clearance in July - PALO ALTO, Calif., Oct. 28 /PRNewswire/ -- PEAK Surgical, Inc., a medical device company that...

GeoVax's DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial

ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based biotechnology company, developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today it has shipped both DNA and MVA co...

Scientists use light to control proteins

A team of researchers from Penn State and the University of Texas Southwestern Medical Center has discovered a way to use light to control certain proteins that catalyze biochemical reactions. "This is one of the first examples of someone successfully controlling the activity of a protein using l...